An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML
Dyantha I. van der Lee(Leiden University Medical Center), Marieke Griffioen(Leiden University Medical Center), Kees L. M. C. Franken(Leiden University Medical Center), Karl J. Harber(Amsterdam Neuroscience), Peter A. van Veelen(Leiden University Medical Center), Rob N. de Jong(Genmab (Netherlands)), Jan W. Drijfhout(Leiden University), Dennis F.G. Remst(Leiden University Medical Center), Arend Mulder(Leiden University Medical Center), Hendrik Veelken(University of Freiburg), Michel G.D. Kester(Leiden University Medical Center), Tassilo L A Wachsmann(Leiden University Medical Center), Lisanne M. Roelofsen(Leiden University Medical Center), Mirjam H.M. Heemskerk(Leiden University Medical Center), Georgia Koutsoumpli(Leiden University Medical Center), JH Falkenburg(Leiden University), Annemiek Schouten(Leiden University Medical Center), M. Wilhelmina Honders(Leiden University Medical Center), Renate S. Hagedoorn(Leiden University Medical Center), Rogier M. Reijmers(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 14
Related Papers
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
|Science Translational Medicine|2016|916
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.
|The Journal of Immunology|1994|345
Essential role of stromally induced hedgehog signaling in B-cell malignancies
|Nature Medicine|2007|321